文献速递眼底病与葡萄膜炎

TRPV1和TRPV4通道参与视网膜血管新生

Involvement of TRPV1 and TRPV4 Channels in Retinal Angiogenesis.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2019-01-01

研究探讨TRPV1和TRPV4通道在视网膜血管新生中的作用,使用原代视网膜微血管内皮细胞(RMECs)进行RT-PCR、Western印迹、免疫标记、钙信号和全细胞膜片钳研究,并在氧诱导视网膜病变(OIR)小鼠模型中评估药理阻断剂的效果。结果显示TRPV1和TRPV4在RMECs中功能性表达并形成异源多聚体复合物,阻断任一通道可抑制体外血管新生并减少OIR模型中的视网膜新生血管、促进缺血视网膜的生理性血管再通。结论认为TRPV1和TRPV4通道是视网膜血管增殖性疾病治疗干预的有前景靶点。

要点

  • TRPV1和TRPV4通道在视网膜微血管内皮细胞中功能性表达并形成异源多聚体复合物。
  • 药理抑制TRPV1或TRPV4可抑制体外视网膜血管新生,机制涉及小管形成的调节。
  • 在OIR小鼠模型中,抑制任一通道可减少视网膜新生血管并促进生理性血管再通。

核心结论

  • TRPV1和TRPV4通道是视网膜血管增殖性疾病治疗干预的有前景靶点。

研究设计与样本

  • 使用原代视网膜微血管内皮细胞(RMECs)进行RT-PCR、Western印迹、免疫标记、钙信号和全细胞膜片钳研究。
  • 在体外使用出芽形成、细胞迁移、增殖和小管形成实验评估TRPV1和TRPV4药理阻断剂对血管新生活性的影响,并在氧诱导视网膜病变(OIR)小鼠模型中进行体内评估。
  • 使用邻位连接实验(PLA)和电生理记录评估RMECs中TRPV1和TRPV4通道的异源多聚化。

主要发现

  • 在RMECs中鉴定到TRPV1 mRNA和蛋白表达,TRPV1标记主要定位于细胞质,部分区域与质膜共定位。
  • 视网膜铺片中完整血管的内皮细胞TRPV1染色模式大致相似。
  • 膜片钳记录证实RMECs中TRPV1和TRPV4的功能性表达。
  • 药理抑制TRPV1或TRPV4通道通过涉及小管形成调节的机制抑制体外视网膜血管新生。
  • 阻断这些通道对体外VEGF刺激的血管新生或钙信号无影响。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We investigate the contribution of TRPV1 and TRPV4 channels to retinal angiogenesis. METHODS: Primary retinal microvascular endothelial cells (RMECs) were used for RT-PCR, Western blotting, immunolabeling, Ca2+ signaling, and whole-cell patch-clamp studies while localization of TRPV1 also was assessed in retinal endothelial cells using whole mount preparations. The effects of pharmacologic blockers of TRPV1 and TRPV4 on retinal angiogenic activity was evaluated in vitro using sprout formation, cell migration, proliferation, and tubulogenesis assays, and in vivo using the mouse model of oxygen-induced retinopathy (OIR). Heteromultimerization of TRPV1 and TRPV4 channels in RMECs was assessed using proximity ligation assays (PLA) and electrophysiologic recording. RESULTS: TRPV1 mRNA and protein expression were identified in RMECs. TRPV1 labelling was found to be mainly localized to the cytoplasm with some areas of staining colocalizing with the plasma membrane. Staining patterns for TRPV1 were broadly similar in endothelial cells of intact vessels within retinal flat mounts. Functional expression of TRPV1 and TRPV4 in RMECs was confirmed by patch-clamp recording. Pharmacologic inhibition of TRPV1 or TRPV4 channels suppressed in vitro retinal angiogenesis through a mechanism involving the modulation of tubulogenesis. Blockade of these channels had no effect on VEGF-stimulated angiogenesis or Ca2+ signals in vitro. PLA and patch-clamp studies revealed that TRPV1 and TRPV4 form functional heteromeric channel complexes in RMECs. Inhibition of either channel reduced retinal neovascularization and promoted physiologic revascularization of the ischemic retina in the OIR mouse model. CONCLUSIONS: TRPV1 and TRPV4 channels represent promising targets for therapeutic intervention in vasoproliferative diseases of the retina.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. O'Leary C, McGahon MK, Ashraf S, et al. Involvement of TRPV1 and TRPV4 Channels in Retinal Angiogenesis. Invest Ophthalmol Vis Sci. 2019. PMID: 31369032. doi:10.1167/iovs.18-26344

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。